Literature DB >> 33975362

Risk Factors and Clinical Characteristics of Metabolic Bone Disease of Prematurity.

Mehmet Mutlu1, Filiz Aktürk-Acar1, Şebnem Kader1, Yakup Aslan1, Gülay Karagüzel2.   

Abstract

OBJECTIVE: The study aimed to analyze the risk factors and clinical features of metabolic bone disease of prematurity (MBDP) in premature infants compared with infants of similar gestational age and birthweight without MBDP. STUDY
DESIGN: This retrospective case-control study was performed by comparing 81 cases of MBDP with 63 controls to identify potential risk factors. Premature infants with a gestational age ≤33 weeks and birthweight <1,500 g were included. Medical records were examined in terms of maternal conditions, potential risk factors, and clinical characteristics.
RESULTS: Bone fractures and invasive ventilator dependence were the most common clinical features of MBDP. Duration of invasive ventilation and total mechanical ventilation days, necrotizing enterocolitis, corticosteroid use, anticonvulsive drug use, duration of dexamethasone and caffeine use, total parenteral nutrition, and length of hospitalization were significantly higher in neonates with MBDP (p < 0.05). Breastfed neonates and those receiving human milk fortifier had a lower incidence of MBDP than those premature formula or mixed feeding (p < 0.05). Anticonvulsive drug use (odds ratio: 2.935; 95% confidence interval: 1.265-6.810) was identified as a risk factor for MBDP at multiple regression analysis.
CONCLUSION: Our results show that anticonvulsive drug use is a significant risk factor for the development of MBDP. If long-term use is not required, anticonvulsive drugs should be stopped as soon as possible. Further studies involving patients with MBDP are required to determine the risk factors and clinical features. KEY POINTS: · MBDP is a multifactorial disorder.. · Anticonvulsive drug use is an important risk factor for the development of MBDP.. · Bone fractures and invasive ventilator dependence are the most common clinical features of MBDP.. Thieme. All rights reserved.

Entities:  

Year:  2021        PMID: 33975362     DOI: 10.1055/s-0041-1729559

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  [Expert consensus on the follow-up management of bronchopulmonary dysplasia in preterm infants after discharge].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

2.  Risk factors for metabolic bone disease of prematurity: A meta-analysis.

Authors:  Jie Wang; Qian Zhao; Baochang Chen; Jingfei Sun; Jiayu Huang; Jinfeng Meng; Shangbin Li; Weichen Yan; Changjun Ren; Ling Hao
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.